Rhinovirus (RV) infections trigger exacerbations of airways disease, but underlying mechanisms remain unknown. We hypothesized that RV and cytokines present in inflamed airways combine to induce augmented airway epithelial cell chemokine expression, promoting further inflammation. To test this hypothesis in a cellular system, we examined the combined effects of RV39 and TNF-, a cytokine increased in asthma and chronic obstructive pulmonary 
INTRODUCTION
Viral infections trigger asthma in 80% of exacerbations in children (30) and 44% in adults (39). Rhinovirus (RV) is the major virus found in these exacerbations, with a recent study detecting RV in 82% of children admitted to an emergency room for acute asthma (33). In chronic obstructive pulmonary disease (COPD), between 27 to 56% of exacerbations are associated with respiratory viral infections, and RV is the most common virus isolated (22, 50 ).
The precise mechanisms by which RV causes exacerbations is unknown.
RV is a positive, single-stranded RNA virus from the Picornaviridae family responsible for the majority of common colds. To date, approximately 100 serotypes of RV have been detected with 90% of serotypes (e.g. RV14, RV16 and RV39) using intercellular adhesion molecule (ICAM)-1 as a receptor. The kinetics of Picornavirus replication are rapid, the cycle being completed in 5-10 hours. A small amount of RV2 synthesis occurs as early as 3 h after infection (29) .
Clinical studies suggest that RV stimulates exacerbations of asthma by inducing bronchial epithelial cell production of the ELR(+) neutrophil chemoattractant, IL-8/CXCL8, leading to a neutrophilic inflammatory response (18, 20, 25, 44) . Two other ELR (+) C-X-C chemokines, epithelial neutrophil attractant (ENA)-78/CXCL5 and growth-related oncogene (GRO)-/CXCL1, are increased in the airways of patients with COPD exacerbations (1, 21, 46) . RV infection has been shown to increase expression of IL-8, ENA-78 and GRO-in cultured airway epithelial cells (16, 23, 38, 49, 52, 57, 59) . After RV16 infection, asthmatic patients show increased levels of IL-8 in their nasal lavage which correlates with the level of airways responsiveness (25) , in contrast to unaffected individuals in whom IL-8 does not increase (13) .
Together, these data suggest that RV infection of airway epithelial cells may potentiate preexisting pro-inflammatory pathways, enhancing chemokine production and airway inflammation.
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To test the hypothesis that RV infection and cytokines present in inflamed airways combine to induce augmented airway epithelial cell responses, thereby promoting further airway inflammation, we examined the effect of RV39 on airway epithelial cell C-X-C chemokine production in response to TNF-. TNF-is produced by macrophages, T cells, mast cells and epithelial cells, and is increased in asthmatic airways (2, 7, 8) . Sputum TNF-is also increased during acute COPD exacerbations (12) . Finally, segmental allergen challenge increases bronchoalveolar TNF-levels in allergic subjects, and the effect is potentiated by prior RV16 infection (9). We found that RV39 and TNF-induce synergistic increases in C-X-C chemokine production, thereby providing a cellular mechanism for RV-induced exacerbations of airways disease.
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MATERIALS AND METHODS
Cell culture. 16HBE14o-human bronchial epithelial cells originating from bronchial epithelial tissue transfected with pSVori-, containing the origin-defective SV40 genome (11), were provided by Dr. Steven White (University of Chicago). Cells were grown in MEM supplemented with 10% FBS, 1% penicillin-streptomycin and 2 mM of L-glutamine.
Primary human bronchial epithelial cell cultures obtained from lung transplant donor tracheas (University Health Network, Toronto) were grown under submerged conditions in bronchial epithelial cell growth medium (Cambrex Bio Science, Walkersville, MD) containing epidermal growth factor (25 ng/ml), bovine pituitary extract (65 ng/ml), all-trans retinoic acid (5x10 -8 M), BSA (1.5 µg/ml), hydrocortisone (0.5 µg/ml), insulin (5 µg/ml), transferrin (10 µg/ml), epinephrine (0.5 µg/ml), triiodothyronine (6.5 ng/ml), gentamycin (50 µg/ml) and amphotericin (50 µg/ml). In selected experiments, cells were cultured at air-liquid interface, as described (48) .
Generation of RV stocks. RV39 was obtained from American Type Culture Collection (Manassas, VA) and viral stocks were generated as previously described (18) . Briefly, HeLa cells were infected with RV until 80% of the cells were cytopathic. Hela cell lysates were harvested and cellular debris pelleted by centrifugation (10,000 x g for 30 min at 4°C). RV was concentrated and purified by centrifugation with a 100,000 MW cutoff Centricon filter (2,000 rpm at 4°C for 8 h; Millipore, Billerica, MA) (42) . For experiments measuring phosphorylation of extracellular signal regulated kinase (ERK), we further decreased the possibility of contamination by serum or HeLa cellular proteins by infecting the HeLa cells in serum-free medium and harvesting the cell-conditioned media rather than cell lysates. Virus was titered by infecting confluent HeLa monolayers with serially diluted RV (range: undiluted to 10 -9
) and assessing cytopathic effect five days after infection. TCID 50 values were determined by the Spearman-Karber method (31) . In some experiments, RV39 was UV-irradiated on ice for 30 min using a UVB CL-1000 Crosslinker at 1200 µJ/cm 2 (42) . The effect of UV irradiation was confirmed by the absence of a cytopathic effect on HeLa cell monolayers. 
Data analysis. Statistical significance was assessed by analysis of variance (ANOVA).
Differences identified by ANOVA were pinpointed by the Student Newman-Keuls' multiple range test.
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9 RESULTS
RV39 and TNF-have cooperative effects on C-X-C chemokine expression in human
airway epithelial cells. 16HBE14o-human bronchial epithelial cells were infected with RV39 (1 h at 33 0 C) and stimulated with TNF-(0.3 to 10 ng/ml). Forty-eight hours after infection, cell supernatants were collected and examined for the C-X-C chemokines IL-8 and ENA-78. RV39
and TNF-each independently increased IL-8 and ENA-78 production, but RV39 infection increased TNF--induced chemokine production significantly above that induced by TNFalone ( Figures 1A and B) . In some cases the effects were additive, but in other instances synergistic (greater than additive) increases in protein expression were noted. For example, RV39 and TNF-(3 ng/ml) each stimulated 16HBE14o-cells to produce approximately 1000 pg/ml IL-8 over the 48 h treatment period, but the combination increased mean IL-8 to nearly 4000 pg/ml. Based on the synergistic effects of RV39 and 3 ng/ml TNF-, this concentration was used for subsequent experiments.
We extended our studies to mucociliary-differentiated primary human tracheal epithelial cells. Supernatants from the basolateral surface were collected and measured for IL-8 and ENA-78 expression. RV39 infection increased TNF--induced IL-8 protein levels relative to that found after TNF-alone ( Figures 1C and D ). These data demonstrate that the synergistic effects observed in the 16HBE14o-cells also occur in a more physiological cell culture model.
We examined the potential cooperative effects of RV and TNF-on the protein abundance of GM-CSF. GM-CSF, a stimulus of granulocyte (neutrophil, eosinophil) differentiation and degranulation, is increased in the airways of patients with asthma (28, 51, 55) and COPD (3). RV and TNF-had synergistic effects on GM-CSF protein abundance ( Figure   1E ). At the concentrations of RV and TNF-employed, we did not observe cooperative increases in IFN-inducible protein-10/CXCL10, eotaxin/CCL11 or regulated upon activation, normal T-cell expressed and secreted (RANTES)/CCL5 (data not shown).
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Effects of RV39 and TNF-on transcription from the IL-8 promoter. We examined the effects of RV39 and TNF-on transcription from the IL-8 promoter. 16HBE14o-cells were transfected with -162/+44 fragment of the full-length human IL-8 promoter subcloned into a luciferase reporter. Cells were infected with RV39 (1 h at 33ºC) and stimulated with TNF-(3 ng/ml for an additional 24h). RV39 and TNF-induced synergistic increases in reporter activity relative to RV39 or TNF-alone ( Figure 1F ), suggesting that the observed cooperative increases in IL-8 production are transcriptionally regulated. promoter ( Figure 5C ). Together, these data suggest that ERK is required for RV39-mediated augmentation of TNF--induced IL-8 expression. 59). However, the exact mechanism by which RV induces exacerbations is unknown. We therefore examined the effect of RV39 on airway epithelial cell C-X-C chemokine production in response to TNF-, which is increased in asthmatic airways (2, 7, 8) and during acute COPD exacerbations (1, 12, 21) . The level of TNF-in diseased airways has varied widely, but concentrations in the ng/ml range have been found (1, 8, 9) . We found that RV39 infection significantly increases TNF--induced IL-8 and ENA-78 expression, and that the cooperative effects on IL-8 expression were mediated in a transcriptional manner. We also found that the combination of RV and TNF-induced synergistic increases in airway epithelial cell GM-CSF expression. GM-CSF have also been implicated in the pathogenesis of asthma and COPD exacerbations (3) . Together, these data prove the principle that RV infection and pro-asthmatic cytokines can produce cooperative effects on airway epithelial cell chemokine expression, and provide a cellular mechanism for RV-induced exacerbations of asthma and COPD.
Potential contribution of changes in ICAM-
We considered the possibility that TNF--induced alterations in RV receptor expression were responsible for the observed cooperative effects. TNF-stimulation increases expression of ICAM-1 in airway epithelial cells (6, 34) . In the present study, we confirmed that TNFincreases surface ICAM-1 expression in 16HBE14o-human bronchial epithelial cells. We also found that TNF-treatment increased the number of RV39 transcripts at 24 h after stimulation, It is also conceivable that the cooperative effects of RV39 and TNF-are due to synergistic expression of an IL-8-inducing chemokine. However, we were only able to detect a synergistic increase in IFN-protein expression at 24 h after co-stimulation, suggesting that, for the most part, synergistic effects between RV and TNF-are not due to autocrine production of IL-8-inducing cytokines.
We have previously shown that, in 16HBE14o-human bronchial epithelial cells, maximal TNF--induced transcription from the IL-8 promoter requires transactivation of both the NF-B
and AP-1 sites; the NF-kB site is required for TNF-responsiveness, whereas the AP-1 site functions as a basal level enhancer. Based in part on the rapid response in IL-8 protein expression following RV and TNF-stimulation, we hypothesized that RV augments TNF--induced IL-8 expression by activation of ERK/AP-1 signaling. First, we tested whether the augmented responses were transcriptionally mediated. Consistent with this mechanism, RV39
and TNF-induced synergistic increases in IL-8 promoter activity relative to RV39 or TNFalone. Second, we examined the effect of RV and TNF-on airway epithelial cell AP-1 transactivation. We found that RV39 significantly increased activity of an AP-1 reporter plasmid.
Third, we found that RV39 infection, but not TNF-, induced significant ERK phosphorylation. We conclude that RV infection enhances cytokine-induced IL-8 expression by activation of the ERK/AP-1 signaling pathway. These data provide a cellular mechanism for RV-induced exacerbations of airways disease, and identify avenues for future study. 16HBE14o-cells were pre-incubated (1 h) with U0126, a specific chemical inhibitor for MEK, the upstream activator of ERK, and then infected with RV39 and stimulated with TNF-.
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